Oncology Institute Inc [TOI] stock is trading at $3.19, down -0.62%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The TOI shares have gain 6.69% over the last week, with a monthly amount glided 28.63%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Oncology Institute Inc [NASDAQ: TOI] stock has seen the most recent analyst activity on May 15, 2025, when BTIG Research initiated its Buy rating and assigned the stock a price target of $7. On September 14, 2022, Guggenheim initiated with a Buy rating and assigned a price target of $7 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $10 on August 15, 2022.
Oncology Institute Inc [TOI] stock has fluctuated between $0.13 and $3.50 over the past year. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Oncology Institute Inc [NASDAQ: TOI] shares were valued at $3.19 at the most recent close of the market. An investor can expect a potential return of 150.78% based on the average TOI price forecast.
Analyzing the TOI fundamentals
Oncology Institute Inc [NASDAQ:TOI] reported sales of 403.15M for the trailing twelve months, which represents a growth of 10.29%. Gross Profit Margin for this corporation currently stands at 0.1% with Operating Profit Margin at -0.13%, Pretax Profit Margin comes in at -0.16%, and Net Profit Margin reading is -0.17%. To continue investigating profitability, this company’s Return on Assets is posted at -0.41, Equity is -5.1 and Total Capital is -0.5. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 5.61.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.09 points at the first support level, and at 3.00 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.27, and for the 2nd resistance point, it is at 3.36.
Ratios To Look Out For
For context, Oncology Institute Inc’s Current Ratio is 1.79. In addition, the Quick Ratio stands at 1.59 and the Cash Ratio stands at 0.67. Considering the valuation of this stock, the price to sales ratio is 0.71, the price to book ratio is 55.96.
Transactions by insiders
Recent insider trading involved M33 Growth I L.P., Director, that happened on May 20 ’25 when 1.8 million shares were sold. Director, M33 Growth I L.P. completed a deal on May 20 ’25 to sell 0.2 million shares. Meanwhile, 10% Owner TOI M, LLC bought 0.2 million shares on May 20 ’25.
